Success Stories: EB-2 NIW and EB1A Approved for Pharmaceutical Scientist

Client’s Testimonial:

“It is amazing news. I have no words to thank you. I want to thank all attorneys and any personnel involved in the filing. I am very impressed with how you make a case. With 309 citations, it was a nightmare to get EB1A. Thank you so much for your help, support, and quick service.”

On July 11^th, 2025, and January 22^nd, 2025, we received another EB-2 NIW (National Interest Waiver) and EB-1A (Alien of Extraordinary Ability) approvals for a Research Scientist in the Field of Pharmaceutical Science (Approval Notice).

General Field: Pharmaceutical Science and Pharmacology

Position at the Time of Case Filing: Post-Doctoral Research Scholar

Country of Origin: India

State of Residence at the Time of Filing: Iowa

Approval Notice Date: : July 11^th, 2025 (NIW) and January 22^nd, 2025 (EB1A)

Processing Time: 1 year, 6 months, 5 days (NIW) / 4 months, 19 days (EB1A) (Premium Processing Requested)

Case Summary:

We are pleased to share the success story of our client, a distinguished expert in pharmaceutical science and pharmacology, who has achieved both EB-2 NIW and EB1A (Extraordinary Ability) approvals with the legal guidance of the North America Immigration Law Group (NAILG).

Our client’s research plays a vital role in addressing the rising burden of stroke in the U.S. and globally. By uncovering new pathways for therapeutic intervention, his work directly supports the development of more precise and effective treatments for neurological conditions. These contributions not only advance scientific discovery but also promise long-term improvements in patient outcomes and public health.

To support his NIW and EB1A petitions, NAILG meticulously documented our client’s achievements, focusing on both the national importance of his research and the exceptional merit of his qualifications. Notably, our client’s EB1A petition initially received a Notice of Intent to Deny (NOID), but our team provided a comprehensive and persuasive response that successfully led to approval on January 22, 2025. This outcome underscores both the strength of our client’s case and NAILG’s experience in navigating complex adjudications.

NAILG’s petition demonstrated the significance of his record with the following supporting details:

18 peer-reviewed journal articles (4 first-authored), 1 book chapter, and 6 abstracts
309 citations on Google Scholar
At least 80 peer reviews completed

Additionally, an expert testimonial submitted with the petition described his influence on the field:

“In summary, [client] is a highly influential and uniquely skilled figure in
pharmaceutical science and pharmacology. His research consistently improves medical research initiatives worldwide, empowering rapid and effective developments in drug discovery. Ensuring the continuation of [client]’s work is thus deeply important to the nation.”

Our client’s EB-2 NIW and EB-1A approval stands as a testament to both the value of his scientific contributions and the strength of NAILG’s petition strategy. We are proud to have guided him through this process and look forward to the continued impact of his research on neurological health and therapeutic innovation.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.